|
CNOT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.716500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.234300E-02 |
| Normal-vs-Stage2 |
2.268600E-01 |
| Normal-vs-Stage3 |
2.095600E-01 |
| Normal-vs-Stage4 |
5.797200E-01 |
| Stage1-vs-Stage2 |
8.420000E-01 |
| Stage1-vs-Stage3 |
9.576800E-01 |
| Stage1-vs-Stage4 |
7.611800E-01 |
| Stage2-vs-Stage3 |
8.388000E-01 |
| Stage2-vs-Stage4 |
7.097400E-01 |
| Stage3-vs-Stage4 |
7.994600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.790400E-02 |
| Normal-vs-AfricanAmerican |
5.481100E-03 |
| Normal-vs-Asian |
8.210800E-01 |
| Caucasian-vs-AfricanAmerican |
1.963960E-01 |
| Caucasian-vs-Asian |
6.145200E-01 |
| AfricanAmerican-vs-Asian |
3.432400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.519600E-02 |
| Normal-vs-Female |
4.164100E-03 |
| Male-vs-Female |
1.742760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.712200E-01 |
| Normal-vs-Extreme_Weight |
3.910200E-01 |
| Normal-vs-Obese |
1.209800E-02 |
| Normal-vs-Extreme_Obese |
1.977150E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.330800E-01 |
| Normal_Weight-vs-Obese |
2.739600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.304840E-01 |
| Extreme_Weight-vs-Obese |
1.086990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.994640E-01 |
| Obese-vs-Extreme_Obese |
2.644400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.700400E-03 |
| Normal-vs-Age(41-60Yrs) |
6.397300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.891440E-01 |
| Normal-vs-Age(81-100Yrs) |
8.334200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.404800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.081020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.576400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.876170E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.583800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.443200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.350700E-04 |
| Normal-VS-Type2 PRCC |
4.418600E-01 |
| Normal-VS-KIRP CIMP |
6.289400E-01 |
| Normal-VS-Unclassified PRCC |
3.960100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.73376000000003E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.121800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.225600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.421400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.453970E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.233400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.992200E-01 |
| Normal-vs-N1 |
1.342040E-02 |
| Normal-vs-N2 |
8.186800E-01 |
| N0-vs-N1 |
6.436500E-03 |
| N0-vs-N2 |
8.852400E-01 |
| N1-vs-N2 |
2.314400E-01 |
|
|
